To evaluate expression of E-cadherin and its transcriptional repressor, ZEB1, in human breast cancer cell lines, protein and mRNA levels were determined by utilizing western blot or reverse-transcriptase PCR methods at 24 and 48 h post SK228 treatment (Figures 3A and B). This evidence concerns the gene CDH1 and breast cancer.